Resultados: 6

Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection

Plos negl. trop. dis; 18 (2), 2024
Background: Trypanosoma cruzi and HIV coinfection can evolve with depression of cellular immunity and increased parasitemia. We applied quantitative PCR (qPCR) as a marker for preemptive antiparasitic treatment to avoid fatal Chagas disease reactivation and analyzed the outcome of treated cases. Methodol...

Consequências clínicas da COVID-19 em pessoas com HIV/AIDS: uma revisão integrativa da literatura

O objetivo desse estudo foi investigar as características e consequências clínicas da infecção pelo coronavírus em pessoas com HIV. Trata-se de uma revisão integrativa da literatura, que utilizou de publicações das bases PubMed e MedLine. A captura se deu com a articu...

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data

The lancet; 3 (6), 2021
Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, which are typically transmitted via respiratory droplets, are leading causes of invasive diseases, including bacteraemic pneumonia and meningitis, and of secondary infections subsequent to post-viral respiratory disease. The ai...

Comparison of the nasopharynx microbiome between influenza and non‐influenza cases of severe acute respiratory infections: a pilot study

Health Sci Rep; 1 (6), 2018
Aims: Influenza A virus (IAV) can cause severe acute respiratory infection (SARI), and disease outcome may be associated with changes in the microbiome of the nasopharynx. This is a pilot study to characterize the microbiome of the nasopharynx in patients hospitalized with SARI, infected and not infected...